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Purpose.Althoughesophagealcapsuleendoscopy(ECE)isreportedlyusefulinthediagnosisofesophagealvarices(EV),fewreports
have described the beneﬁts of this technique in Asian countries. The present paper evaluates the usefulness of ECE for diagnosing
EV in Japanese patients with cirrhosis. Methods. We examined 29 patients with cirrhosis (20 males and 9 females; mean age 60
years; Child-Pugh classiﬁcation A/B/C; 14/14/1) using ECE followed by esophagogastroduodenoscopy (EGD). High-risk EV were
deﬁned as F2 and/or RC2 and above. Results. The sensitivity and speciﬁcity of ECE for the diagnosis of high-risk EV were 92% and
80%, respectively. Conclusions. The ﬁndings showed that ECE is a highly sensitive method of diagnosing high-risk EV that requires
endoscopic or pharmacological therapy. Thus, ECE might be a useful method for the screening and followup of EV in patients
with cirrhosis.
1.Introduction
Esophageal varices (EV) arise when the hepatic-venous pres-
sure gradient reaches >10–12mmHg [1], and they comprise
a serious complication of portal hypertension. The reported
incidence of EV ranges between 5% and 12% [2], but about
90%ofpatientswithcirrhosiswilldevelopEV.Theestimated
annual rate of conversion of small EV to large EV in such
patients is 12% [3]. Furthermore, between 25% and 30%
of EV in cirrhotic patients will bleed. Despite advances in
the management of acute variceal bleeding [4, 5], mortality
rates after bleeding from EV remain at around 20% at 6
weeks. Primary prophylaxis with pharmacological agents or
endoscopic treatment has been adopted to reduce mortality
associated with variceal bleeding [6–8]. However, treatment
with beta blockers and/or endoscopic band ligation is useful
for the primary prophylaxis of variceal bleeding only in some
patients with high-risk EV [1, 8–10]. Therefore, endoscopic
screening is required to detect high-risk EV in patients with
liver cirrhosis so that appropriate prophylactic treatment can
be initiated [8, 10].
Esophageal capsule endoscopy (ECE) diagnostic systems
(PillCam ESO; Given Imaging, Yokneam, Israel) enable visu-
alization within the digestive tract including the esophagus,
without the need for the administration of sedatives. If
proven feasible and accurate for diagnosing EV in liver
cirrhosis, this system could become an alternative method to
standard upper gastrointestinal endoscopy.
Several reports have indicated that ECE can provide clear
images of esophageal diseases, including Barrett’s esophagus
and esophagitis [11–14], and that it is useful for detecting EV
[5, 13, 15]. However, few such reports have been generated
from Asian countries, including Japan. Thus, the present
prospectivestudyassessedthefeasibilityandaccuracyofECE
in diagnosing EV in Japanese patients with liver cirrhosis.
2. Patients andMethods
The present study compares the diagnostic accuracy of
ECE for detecting EV compared with that of conventional
esophagogastroduodenoscopy (EGD), which is the current2 Gastroenterology Research and Practice
gold standard for the EV diagnosis. Esophageal varices were
recorded according to the general rules of the Japanese
Society for Portal Hypertension [16]( Table 1). Endoscopic
signs predictive of EV bleeding comprised moderate or large
( F 2o rF 3 )b l u ev a r i c e sw i t hm a r k e dr e ds i g n s( R C 2o rR C 3 )
on their surface [17, 18]. According to the retrospective
calculations of Imazu et al., these signs correspond to a
bleeding risk of ≥64% [19]. Therefore, we deﬁned high-risk
varices as F2 and/or RC2 and above. The EGD reference and
ECE ﬁndings were compared.
All of the enrolled patients had cirrhosis and some
had suspected EV. The inclusion criteria were aged ≥18
years, prior endoscopic conﬁrmation of EV and currently
under clinical surveillance, or suspected portal hypertension
with current endoscopic screening for EV. The exclusion
criteria comprised a history of, or current dysphagia, known
esophageal diverticulum, known or suspected intestinal
obstruction, pregnancy, a history of gastrointestinal surgery
other than uncomplicated cholecystectomy or appendec-
tomy, having an implanted cardiac pacemaker or any other
electromedical device and any condition that might pre-
clude compliance with the study and/or the PillCam ESO
instructions. The study proceeded in accordance with the
ethical principles outlined in the Declaration of Helsinki, in
compliance with good clinical practice and according to the
Jikei University School of Medicine’s regulations. The study
protocol was approved by the Ethics committees of the Jikei
University School of Medicine for biomedical research and
institutional review boards. Written informed consent was
obtained from all patients who met the inclusion criteria and
agreed to participate in the study.
The patients fasted for at least 8 hours before undergoing
ECE and EGD using a modiﬁcation of the simpliﬁed
ingestion protocol (SIP) [20]. Brieﬂy, because EGD was
started immediately after the patients had swallowed the
ECE, pronase (proteases) was administered and then a data
recorder including a recorder belt and sensor array was then
attached to the patients. When the system was secured in
place, seated patients ingested up to 50mL of a mixture
of water and liquid dimethicone (dimethylpolysiloxane) to
reduce bubbles inside the esophagus. The patients then lay
in the right lateral decubitus position and sipped water
(approximately 15mL per sip) before swallowing the ECE.
The patient remained in the same position for 7min
and sipped water every minute. Pharyngeal anesthesia was
applied to supine patients before being returned to the
right lateral decubitus position for EGD. The ECE was the
removed using a basket clamp where possible.
All ﬁndings generated using the ECE were reviewed
by three experienced endoscopists who were blinded to
each patient’s history, with the exception of liver cirrhosis.
All ﬁndings were documented as digital thumbnails. The
examiner also documented the times of the ﬁrst esophageal
and gastric images so that the esophageal transit time could
be determined. The examiner assessed the video for the
presence or absence of EV and any EV present were graded
using the Japanese endoscopic classiﬁcation system [16].
Accuracy was assessed for the form of EVs detected and
the presence of red signs. Rates of agreement between ECE
Table 1: General rules for recording endoscopic ﬁndings of
esophagogastric varices, as published by the Japanese Society for
Portal Hypertension (2004) [16].
Form (F) Shape and size
F0: lesions assuming no varicose appearance
F1: straight small-calibered varices
F2: moderately enlarged, beady varices
F3: markedly enlarged, nodular, or tumor-shaped Varices)
Red color sign (RC)
Red wale marking, cherry Red Spot, hematocytic spot
RC0: absent
RC1: small in number and localized
RC2: intermediate between 1 and 3
RC3: large in number and circumferential
Table 2:Patients’background.ALLC,alcoholiclivercirrhosis;CLC,
HCV-related liver cirrhosis; HCC, hepatocellular carcinoma; LC,
liver cirrhosis NBNC, non-B, non-C liver cirrhosis; PBC, primary
biliary cirrhosis.
Number 29
Age (mean (range)) 66.0 (46–78)
Sex (male/female) 20/9
Underlying disease
CLC 5
ALLC 4
NBNC 2
PBC 1
LC + HCC 17
Child-Pugh class
A/B/C 14/14/1
and EGD, as well as the sensitivity and speciﬁcity of ECE,
were determined.
3. Results
(1) Patients’ backgrounds are shown in (Table 2). All 29 of
the enrolled patients with cirrhosis (mean age, 66.0 ± 8.7
years; male, n = 20; female, n = 9) could ingest the capsule
without diﬃculty, and no technical problems developed.
None of the capsules were retained in the esophagus. Ten
of the patients were under surveillance for EV, whereas the
remaining 19 were undergoing screening. Nine patients had
undergone previous endoscopic sclerotherapy. The median
ECE transit time was 256.1s (range, 4–917s). The EGD
ﬁndingsindicatedthatof22patientswithEV,14,14,andone
had Child-Pugh classiﬁcations of A, B, and C, respectively.
The ECE and EGD ﬁndings from 28 patients were assessed
because the ECE did not reach the esophagogastric junction
in one of them.
(2) Comparison of the accuracy of ECE and EGD in
grading forms (F) of esophagogastric varices. The rates of
agreement between the two techniques for F0, F1, F2, and
F3 were 83%, 80%, 67%, and 66%, respectively.Gastroenterology Research and Practice 3
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Figure 1: Images acquired using esophageal capsule endoscopy show (a–c) form (F) and (d–f) red (RC) signs of esophagogastric varices
(EVs). Examples of EVs classiﬁed as F1 (a), F2 (b), and F3 (c), as well as RC0 (d), RC1 (e), and RC2 (f).
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Figure 2: Images from a patient with good agreement between EGD (a) and ECE (b). This patient was classiﬁed as F1RC2 using both
techniques.
(3) Comparison of the accuracy of the grading of red
(RC) signs in esophagogastric varices by ECE and EGD.
The rates of agreement between the two techniques for
RC0, RC1, RC2, and RC3 were 90%, 33%, 27%, and 0%,
respectively.
(4) Sensitivity and speciﬁcity of ECE for diagnosing EV
(Table 3 and Figures 1–3). The sensitivity and speciﬁcity of
ECE for diagnosing EV were 95% and 83%, respectively,
whereas those of ECE for diagnosing RC on the variceal sur-
face were 94% and 82%, respectively. Finally, the sensitivity4 Gastroenterology Research and Practice
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Figure 3: Images from a patient with poor agreement between EGD (a) and ECE (b). Varices were classiﬁed as F3RC1 by EGD (a), but as
F2RC2 by ECE (b).
Table 3: Sensitivity and speciﬁcity of ECE for diagnosing EV.
Detection of high-risk varices (F2 and/or RC2 )
Sensitivity 92% (=12/13)
Speciﬁcity 80% (=12/15)
Detection of RC sign
Sensitivity 94% (=16/17)
Speciﬁcity 82% (=9/11)
Detection of esophageal varices
Sensitivity 95% (=21/22)
Speciﬁcity 83% (=5/6)
and speciﬁcity of ECE for diagnosing high-risk EV requiring
endoscopic therapy were 92% and 80%, respectively.
Figures 2 and 3 show images from patient in whom
results obtained with ECE and EGD agreed and conﬂicted,
respectively.
4. Discussion
Esophageal varices comprise one of the most serious com-
plications of portal hypertension. Merli et al. [3]r e p o r t e d
a 5% and 15% risk of hemorrhage from small and large
EV, respectively. Two-thirds of bleeding EV will rebleed
at some point, with a cumulative mortality of 33% [3].
Both the American Association for the Study of Liver
Diseases (AASLD) and European liver societies recommend
endoscopic screening for EV in patients with chronic liver
diseases such as cirrhosis [21, 22].
SomereportshavedocumentedtheapplicationofECEto
screening for EV. For example, the pilot study of 32 patients
by Eisen et al. found that the sensitivity and speciﬁcity ECE
compared with EGD for evaluating EV was 100% and 89%,
respectively [5]. Furthermore, Lapalus et al. found that ECE
detected grade 2 EV and/or red signs in all of 21 patients
that required primary prophylaxis [15]a n dR a m i r e ze ta l .
reported that the accuracy of their string ECE for diagnosing
EV and portal hypertension in patients with chronic liver
disease was excellent [23]. In another study of 20 patients
with cirrhosis who underwent ECE followed by EGD, the
sensitivity of ECE for detecting EV was 68%, and ECE
identiﬁednineof10EVthathadbeenratedgrade2orhigher
on EGD [24]. Thus, the discrepancy between EGD and ECE
appears greater when detecting smaller varices. Among 50
patients who underwent both ECE and EGD, the accuracy
of ECE to determine the need for prophylaxis was 74%,
with a sensitivity of 63% and a speciﬁcity of 82% [25].
A recent multicenter study of 288 patients found that the
overall agreement between EGD and ECE for detecting EV
was 85.8% and that the sensitivity and speciﬁcity of ECE was
84% and 88%, respectively [26]. In that study, the diﬀerence
inthediagnosisofEVbetweenthetwotechniqueswas15.6%
in favor of EGD. Finally, a French multicenter study of 120
patients found that the sensitivity and speciﬁcity of ECE
for the indication of primary prophylaxis of 77% and 88%,
respectively [27].
The sensitivity and speciﬁcity of ECE for a diagnosis
of EV were 95% and 83%, respectively, compared with
94% and 82%, respectively, for the diagnosis of RC signs
on the variceal surface. The sensitivity and speciﬁcity of
ECE for the diagnosis of high-risk EV were 92% and 80%,
respectively. Therefore, ECE can sensitively discriminate
high-risk EV that require pharmacological or endoscopic
therapy. Furthermore, ECE might be useful for the screening
and followup of EV in patients with cirrhosis.
We used a modiﬁed SIP. Although the transit time was
only 4 seconds in one of the patients, EVs could still be
thoroughly examined because 56 images of the esophagus
were acquired. Therefore, diﬃculties with analyzing ECE
images are most often associated with esophageal secretions
ratherthanwithashorttransittime.Eisenetal.reportedthat
a major limitation of using ECE to grade EV was related to
the lack of air insuﬄation [5]. However, given that grading is
usually overestimated when using ECE compared with EGD,
we believe that ECE can be used to grade EV.
We found a tendency to overestimate RC signs; in
particular, RC1 was diagnosed as RC2. However, the ﬁndings
around the esophagogastric junction taken by the ECE areGastroenterology Research and Practice 5
probably true considering the clarity of the images, unlike
those acquired using EGD.
Delvaux et al. examined 98 patients using ECE, but the
capsule did not enter the stomach of 15 patients during a 20-
minute recording period [28]. The capsule did not reach the
esophagogastric junction in only one patient in the present
study and was probably trapped in her stomach because
the patient was lying down during both the ECE and EGD
procedures.
A newer ECE model, namely, the PillCam ESO II (Given
Imaging, Yokneam, Israel), has been developed that is
supposedtoacquireclearerimagesthanthepreviousversion.
However, the data from the present study suggest that the
PillCam ESO is suﬃcient for detecting EV. Further studies
should determine diﬀerences in images obtained by the two
ECE systems.
Abbreviations
ECE: Esophageal capsule endoscopy
EGD: Esophagogastroduodenoscopy
EV: Esophageal varices.
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